Indivior Pharmaceuticals Inc
USD40.88
-0.39 (-0.93%)
CEO
Joseph J. Ciaffoni
IPO Date
2014-12-29
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$41.57
Prev. Close
$41.26
Day Low
$40.58
Day High
$42.04
52W Low
$14.52
52W High
$42.81
Market Cap
$5.10B
Volume
0.26M
| 31 Dec 2023 | FY | 84.1% | -11.8% | 67.5% | -7.3% | -1.48 | 0.98 | -16.5 |
| 31 Dec 2022 | FY | 83.2% | -4.9% | -85.8% | -2.5% | 5.40 | 1.24 | -68.7 |
| 31 Dec 2021 | FY | 83.9% | 25.9% | 101.0% | 11.2% | 1.41 | 1.80 | 12.3 |
| 31 Dec 2020 | FY | 85.0% | -22.9% | -180.5% | -9.7% | 3.48 | 1.98 | -7.3 |
| 31 Dec 2019 | FY | 82.2% | 17.1% | 64.1% | 8.1% | 1.40 | 1.83 | 2.8 |
| 31 Dec 2018 | FY | 86.0% | 27.4% | 398.0% | 17.0% | 3.65 | 1.62 | 3.7 |
| 31 Dec 2017 | FY | 89.3% | 5.3% | -30.0% | 4.2% | -2.37 | 1.43 | 65.1 |
| 31 Dec 2016 | FY | 88.6% | 3.3% | -10.9% | 2.7% | -1.81 | 0.96 | 79.7 |
| 11.0 |
| 30 Sept 2025 | Q3 | 80.3% | 13.4% | -20.3% | 3.0% | -1.72 | 0.96 | 17.9 |
| 30 Jun 2025 | Q2 | 82.8% | 6.0% | -7.0% | 1.2% | -1.42 | 0.90 | 25.3 |
| 31 Mar 2025 | Q1 | 83.5% | 17.7% | -16.4% | 3.4% | -1.29 | 0.88 | 6.3 |
| 31 Dec 2024 | Q4 | 92.3% | 19.7% | -17.0% | 4.5% | -1.08 | 0.89 | 6.7 |
| 30 Sept 2024 | Q3 | 77.5% | 1.3% | -2.4% | 0.3% | -1.70 | 0.83 | 80.5 |
| 30 Jun 2024 | Q2 | 73.6% | -32.4% | 80.2% | -6.3% | -2.32 | 0.85 | -5.5 |
| 31 Mar 2024 | Q1 | 86.6% | 21.5% | 610.5% | 4.2% | 27.90 | 0.92 | 11.7 |
| 31 Dec 2023 | Q4 | 82.6% | 18.4% | -28.3% | 3.1% | -1.48 | 0.98 | 9.8 |